{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:06:33Z","timestamp":1776722793840,"version":"3.51.2"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.12788\/fp.0631","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:20:32Z","timestamp":1764699632000},"source":"Crossref","is-referenced-by-count":1,"title":["Gadolinium Intermediate Elimination and Persistent Symptoms After Magnetic Resonance Imaging Contrast Agent Exposure"],"prefix":"10.12788","volume":"42","member":"5043","published-online":{"date-parts":[[2025,11]]},"container-title":["Federal Practitioner"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/issues\/articles\/1125FED%20MRI%20web_0.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:20:33Z","timestamp":1764699633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/fedprac\/article\/273058\/mixed-topics\/gadolinium-intermediate-elimination-and-persistent-symptoms-after-magnetic-resonance-imaging-contrast-agent-exposure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":0,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]},"published-print":{"date-parts":[[2025,11]]}},"URL":"https:\/\/doi.org\/10.12788\/fp.0631","relation":{},"subject":[],"published":{"date-parts":[[2025,11]]}}}